Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
JMS CoTSE:7702 +1.32%62 EV-to-FCF is -29.40 as of Jul. 30, 2026. GuruFocus rates TSE:7702 with a GF Score™ of 62/100 and a GF Value™ of 円469.13 (Fairly Valued). The stock has 10 warning signs investors should review. Among 417 Medical Devices & Instruments companies, JMS Co ranks worse than 239807.91% on this metric.
EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, JMS Co's Enterprise Value is 円31,605 Mil.
JMS Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,075 Mil. Therefore, JMS Co's EV-to-FCF for today is -29.40.
The historical rank and industry rank for JMS Co's EV-to-FCF or its related term are showing as below:
TSE:7702'
s EV-to-FCF Range Over the Past 10 Years
Min: -171.56 Med: -12.87 Max: 153.18
Current: -29.33
During the past 13 years, the highest EV-to-FCF of JMS Co was 153.18. The lowest was -171.56. And the median was -12.87.
TSE:7702's EV-to-FCF is ranked worse than 100% of 417
companies
in the Medical Devices & Instruments industry
Industry Median: 23.7
vs TSE:7702: -29.33
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
As of today (2026-07-30), JMS Co's stock price is 円459.00.
JMS Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-31.954. Therefore, JMS Co's PE Ratio (TTM) for today is At Loss.
JMS Co (TSE:7702) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
JMS Co's share price for today is 円459.00.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JMS Co's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2026 was 円-31.954.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
JMS Co EV-to-FCF Related Terms
JMS Co EV-to-FCF Historical Data
* Premium members only.
The historical data trend for JMS Co's EV-to-FCF can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Instruments & Supplies subindustry, JMS Co's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
JMS Co EV-to-FCF vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, JMS Co's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where JMS Co's EV-to-FCF falls into.
JMS Co's current Enterprise Value is 円31,605 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. JMS Co's Free Cash Flow for the trailing twelve months (TTM) ended in Mar. 2026 was 円-1,075 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
JMS Co (TSE:7702) has a EV-to-FCF of -29.40 as of Jul. 30, 2026. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on JMS Co and its competitors. According to the industry distribution chart, JMS Co ranks #999999 out of 417 companies in the Medical Devices & Instruments industry.
Is JMS Co's EV-to-FCF too high?
JMS Co's current EV-to-FCF is -29.40. Based on the distribution chart, JMS Co ranks #999999 out of 417 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, JMS Co has a GF Score™ of 62/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does JMS Co's EV-to-FCF compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, JMS Co ranks #999999 out of 417 companies for EV-to-FCF. This places JMS Co in the lower half of its industry. The industry median EV-to-FCF is 23.70. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-FCF for a Medical Devices & Instruments company?
The median EV-to-FCF among Medical Devices & Instruments companies is 23.70, based on 417 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-FCF significantly above this median, while those in the bottom quartile fall well below. However, EV-to-FCF should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-FCF mean?
A high EV-to-FCF can signal that a stock is expensive relative to its fundamentals. EV to FCF ratio is the company's enterprise value divided by free cash flow. View historical data on JMS Co and its competitors. For the Medical Devices & Instruments industry, the median EV-to-FCF is 23.70 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. JMS Co's current EV-to-FCF is -29.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is JMS Co stock overvalued right now?
Based on GuruFocus' analysis, JMS Co (TSE:7702) is currently considered Fairly Valued. The stock's GF Value™ is 円469.13, compared to a current price of 円459.00 — trading 2.2% below its estimated fair value. The current EV-to-FCF is -29.40. JMS Co's overall GF Score™ is 62/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-FCF calculated?
EV-to-FCF is calculated from a company's financial statements. For JMS Co (TSE:7702), the current EV-to-FCF is -29.40 as of Jul. 30, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is JMS Co (TSE:7702) Overvalued in 2026?
Based on GuruFocus' analysis, JMS Co stock appears to be undervalued.
The current stock price of 円459.00 is trading 2.2% below its estimated GF Value™ of 円469.13.
GuruFocus considers JMS Co to be Fairly Valued.
Key valuation signals for TSE:7702:
EV-to-FCF: -29.40
GF Value™: 円469.13 vs. price of 円459.00 (2.2% below fair value)
No single metric tells the full story. See the TSE:7702 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
JMS Co Ltd is a Japan-based medical equipment manufacturer. The company is engaged in the manufacture, sale, export, and import of medical equipment and pharmaceuticals. Products offered by the company include an infusion pump, syringe pump, surgical gown, peritoneal dialysate, dialyzer, mask cap, sheet for treatment, pacemaker, heat exchanger, blood bag, among others. JMS has network operations in various countries including Europe, North America, Asia, the Middle East, Latin America and Africa.
62GF Score
Get the complete analysis for TSE:7702
EV-to-FCF is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7702 has been successfully added to your 
